Difference between revisions of "Varga G"
From Bioblast
Beno Marija (talk | contribs) (Created page with " {{person}}") |
Beno Marija (talk | contribs) |
||
(6 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{EAGLE | |||
|COST=Member}} | |||
{{ | |||
{{Person | |||
|lastname=Varga | |||
|firstname=Gabor | |||
|title=Dr. | |||
|institution=Institute of Surgery | |||
Semmelweis University | |||
|address=Üllői út 26 | |||
|area code=1085 | |||
|city=Budapest | |||
|country=Hungary | |||
}} | |||
{{Labelingperson}} | |||
== MitoEAGLE Inclusiveness Target Countries - Conference Grant == | |||
****: [[MitoEAGLE_Inclusiveness_Target_Countries#Conference_Grant_-_Grand_Period_2|Conference Grant Grand Period 2]] | |||
::: '''[[Media:Gabor_ITC_conference_grant_scientific_report.pdf|Scientific report - WISe3]]''' |
Latest revision as of 11:03, 23 October 2018
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Varga G
MitoPedia topics: EAGLE
COST: Member
Name | Varga Gabor, Dr. |
---|---|
Institution | Institute of Surgery
Semmelweis University |
Address | Üllői út 26, 1085 |
City | Budapest |
State/Province | |
Country | Hungary |
[email protected] | |
Weblink | |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
Barath 2022 Int J Mol Sci | 2022 | Baráth B, Jász DK, Horváth T, Baráth B, Maróti G, Strifler G, Varga G, Sándor L, Perényi D, Tallósy S, Donka T, Jávor P, Boros M, Hartmann P (2022) Mitochondrial side effects of surgical prophylactic antibiotics Ceftriaxone and Rifaximin lead to bowel mucosal damage. Int J Mol Sci 23:5064. https://doi.org/10.3390/ijms23095064 |
Varga 2017 Inflammopharmacology | 2017 | Varga G, Ugocsai M, Hartmann P, Lajkó N, Molnár R, Szűcs S, Jász DK, Érces D, Ghyczy M, Tóth G, Boros M (2017) Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis. Inflammopharmacology 26:261-71. |
Abstracts